Ahmed Mourad Kaghad

Title: Ahmed Mourad Kaghad: Innovator in Tumor-Suppressing Genes

Introduction

Ahmed Mourad Kaghad is a notable inventor based in Montgiscard, France. He has made significant contributions to the field of genetics, particularly in the area of tumor-suppressing genes. With a total of 2 patents, Kaghad's work has the potential to impact cancer research and treatment.

Latest Patents

Kaghad's latest patents include the invention of the Purified SR-p70 protein. This invention relates to new nucleic acid sequences of the family of tumor-suppressing genes associated with the gene for the p53 protein. The corresponding protein sequences are also part of this innovative work. This research is crucial for understanding and potentially combating various forms of cancer.

Career Highlights

Kaghad is currently employed at Sanofi-Aventis, a leading global healthcare company. His role at the company allows him to further his research and development in the field of genetics. His contributions are recognized within the scientific community, and he continues to push the boundaries of innovation in his area of expertise.

Collaborations

Some of Kaghad's notable coworkers include Daniel Caput and Pascual Ferrara. Their collaborative efforts contribute to the advancement of research in tumor-suppressing genes and related fields.

Conclusion

Ahmed Mourad Kaghad is a prominent figure in the realm of genetic research, with a focus on tumor-suppressing genes. His patents and work at Sanofi-Aventis highlight his commitment to advancing medical science. His contributions are vital for future developments in cancer treatment and research.